EUVIMEDEUVIMED entdecken
Crossref

Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North‐East Ethiopia, 2021

Seteamlak Adane Masresha, Atitegeb Abera Kidie, Gedefaw Diress Alen, Getahun Fentaw Mulaw, Fentaw Wassie Feleke, Mesfin Wudu Kassaw, Tadesse Mamo Dejene

Pharmacoepidemiology and Drug Safety · 2023

DOI: 10.1002/pds.5625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2023. Verfasst von Seteamlak Adane Masresha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Woldia University, Woldia, Ethiopia. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acquired immune deficiency syndrome (AIDS) becomes a manageable chronic disease due to the presence of effective prevention, diagnosis, treatment, and care accesses. Viral load cascade analyses are important to identify gaps in human immunodeficiency virus (HIV)/AIDS treatment and care for quality improvements.

Objective

Time to Virological Failure and its Predictors among HIV Infected Individuals on Second Line Antiretroviral Treatment (SLART) in North‐East Ethiopia, 2021.

Methods

Institution‐based retrospective follow‐up study was conducted on 474 HIV‐infected individuals who were on SLART between September 2016 and April 2020. A universal sampling technique was used to recruit study participants. Data were entered by EpiData‐3.3.1 and analyzed by STATA‐14. Cox proportional hazard assumptions were checked to determine the effect of predictor variables on virological failure (VF). The study was conducted from February 1 to April 30, 2021.

Results

The rate of VF in this study was 15.4% with an incidence rate of 4.93 per 100 person‐years. As participants' age and duration of ART use increased by 1 year the hazards of VF was reduced by 2.9% (AHR: 0.971, 95% CI: 0.945, 0.995) and 10.6% (AHR: 0.894, 95% CI: 0.828, 0.963), respectively. The hazards of VF were twice higher among those who were on a non‐protease inhibitor‐based regimen. Individuals who had a history of making enhanced adherence counseling (EAC) sessions during SLART had three times more risk to develop VF (AHR: 3.374, 95% CI: 1.790, 6.361). Conclusion and Recommendations The rate of VF among SLART users was high. Keeping SLART users on PI‐based regimens may improve virological outcomes in HIV care and treatment. Making EAC sessions effective in promoting better ART adherence might reduce VF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acquired Immunodeficiency SyndromeHIV InfectionsAnti-HIV AgentsHumansHIVRetrospective StudiesFollow-Up StudiesEthiopiaAnti-Retroviral AgentsTreatment Failure

Substanzen

Anti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Public Health, Woldia University, Woldia, Ethiopia.
  • Department of Public Health, Debre Markos University, Debre Markos, Ethiopia.
  • Department of Nursing, Woldia University, Woldia, Ethiopia.
  • Department of Public Health, Debre Berhan University, Debre Berhan, Ethiopia.

Zitieren

APA

Masresha, S. A., Kidie, A. A., Alen, G. D., Mulaw, G. F., Feleke, F. W., Kassaw, M. W., & Dejene, T. M. (2023). Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North‐East Ethiopia, 2021. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5625

Vancouver

Masresha SA, Kidie AA, Alen GD, Mulaw GF, Feleke FW, Kassaw MW, et al. Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North‐East Ethiopia, 2021. Pharmacoepidemiology and Drug Safety. 2023. doi:10.1002/pds.5625

BibTeX
@article{Masresha2023,
  author = {Masresha, Seteamlak Adane and Kidie, Atitegeb Abera and Alen, Gedefaw Diress and Mulaw, Getahun Fentaw and Feleke, Fentaw Wassie and Kassaw, Mesfin Wudu and Dejene, Tadesse Mamo},
  title = {Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North‐East Ethiopia, 2021},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2023},
  doi = {10.1002/pds.5625}
}
Kostenlos starten →